Trial Profile
Efficacy and safety trial of mizoribine for polymyalgia rheumatica
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Mizoribine (Primary)
- Indications Polymyalgia rheumatica
- Focus Therapeutic Use
- 04 Feb 2016 New trial record